FDA Approves Improved Chest X-ray Technology

June 22, 2010 – Riverain Medical announced this week that the U.S. Food and Drug Administration (FDA) has granted approval for the newest version of the OnGuard Chest X-ray Computer-Aided Detection (CAD) technology. OnGuard identifies solitary pulmonary nodules that may represent early-stage lung cancer on an existing chest X-ray. This improved performance demonstrates a 73 percent reduction in false positive marks and 50 percent higher relative sensitivity compared to the original product. [1]

More than 200,000 Americans will be diagnosed with lung cancer this year. Only a small percentage of these patients will be diagnosed with lung cancer in the earliest stages when it is most treatable. When lung cancer is detected early, five-year survival rates triple. [2] Multiple studies demonstrate that OnGuard can detect 37 to 50 percent of lung cancers that were missed in the initial interpretation. [3, 4]

“Our published studies demonstrate that OnGuard can detect up to 50 percent of the lung cancers that were missed in the initial interpretation,” says Dr. Charles White, professor and vice chairman of radiology at the University of Maryland School of Medicine. “OnGuard provides physicians with a tool to help identify suspicious nodules in the lungs earlier.”

Also cleared by the FDA is SoftView, a new image enhancement technology that increases the clarity of chest X-rays by suppressing bone on the digital image. The software automatically provides a soft tissue image for every chest X-ray.

For more information: www.riverainmedical.com

References:
1. Riverain Medical Clinical Trial for U.S. FDA Submission
2. American Cancer Society Facts and Figures 2010
3. White, C.; Flukinger, T.; Jeudy, J. and Chen, J. (2009). “Use of a Computer-Aided Detection System to Detect Missed Lung Cancer at Chest Radiography.” Radiology. 252: 273-281.
4. Li, F.; Englemann, R.; Metz, C.; Doi, K. and MacMahon, H. (2008). “Lung Cancers Missed on Chest Radiographs: Results Obtained with a Commercial Computer-aided Detection Program.” Radiology. 246: 273-280.

 


Related Content

News | Proton Therapy

Sept. 28, 2025 — Leo Cancer Care has launched Grace, the company's upright photon therapy system. Grace is named after ...

Time October 03, 2025
arrow
News | Bone Densitometry Systems

Sept. 11, 2025 — Naitive Technologies, a medical technology company developing AI-driven software to reimagine ...

Time September 11, 2025
arrow
News | X-Ray

Sept. 08, 2025 — A new clinical case study, presented by Qure.ai and Hacettepe University, Turkey, at the IASLC World ...

Time September 10, 2025
arrow
News | Mammography

Aug. 19, 2025 — Calidar, Inc., a start-up in precision diagnostic imaging formed out of Duke University, recently ...

Time August 19, 2025
arrow
Feature | X-Ray | By Siân Phillips, MD

Imaging is a crucial diagnostic, treatment and monitoring tool in modern medicine. From diagnosis to disease management ...

Time July 31, 2025
arrow
News | Computed Tomography (CT)

April 17, 2025 — Nano-X Imaging LTD has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

Time April 18, 2025
arrow
News | PACS

April 3, 2025 – Konica Minolta Healthcare Americas, Inc. has launched the next-generation of the Exa Platform with the ...

Time April 15, 2025
arrow
News | X-Ray

March 18, 2025 — GE HealthCare recently announced a collaboration with NVIDIA expanding the existing relationship ...

Time March 19, 2025
arrow
News | Radiology Imaging

Nov. 13, 2024 — Agfa Radiology Solutions will feature live demonstrations of state-of-the-art digital X-ray rooms ...

Time November 14, 2024
arrow
News | Enterprise Imaging

Nov. 13, 2024 – Konica Minolta Healthcare Americas, Inc.has launched Exa Enterprise, an enterprise imaging solution with ...

Time November 14, 2024
arrow
Subscribe Now